These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28391390)

  • 1. Corticosteroids in the management of acute multiple sclerosis exacerbations.
    Smets I; Van Deun L; Bohyn C; van Pesch V; Vanopdenbosch L; Dive D; Bissay V; Dubois B;
    Acta Neurol Belg; 2017 Sep; 117(3):623-633. PubMed ID: 28391390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis.
    de Seze J; Chapelotte M; Delalande S; Ferriby D; Stojkovic T; Vermersch P
    Mult Scler; 2004 Oct; 10(5):596-7. PubMed ID: 15471379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids treatment.
    Pozzilli C; Marinelli F; Romano S; Bagnato F
    J Neurol Sci; 2004 Aug; 223(1):47-51. PubMed ID: 15261560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids for multiple sclerosis: I. Application for treating exacerbations.
    Frohman EM; Shah A; Eggenberger E; Metz L; Zivadinov R; Stüve O
    Neurotherapeutics; 2007 Oct; 4(4):618-26. PubMed ID: 17920542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insights into corticosteroids in multiple sclerosis: war horse or chameleon?
    Krieger S; Sorrells SF; Nickerson M; Pace TW
    Clin Neurol Neurosurg; 2014 Apr; 119():6-16. PubMed ID: 24635918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis and pregnancy.
    Tsui A; Lee MA
    Curr Opin Obstet Gynecol; 2011 Dec; 23(6):435-9. PubMed ID: 22011954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients.
    Leguy S; Lefort M; Lescot L; Michaud A; Vukusic S; Le Page E; Edan G; Kerbrat A; Lebrun-Frenay C; De Sèze J; Laplaud DA; Wiertlewski S; Leray E; Michel L
    J Neurol; 2022 Oct; 269(10):5571-5581. PubMed ID: 35737108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse management in multiple sclerosis.
    Thrower BW
    Neurologist; 2009 Jan; 15(1):1-5. PubMed ID: 19131851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term effects of corticosteroids in multiple sclerosis in terms of the "no evidence of disease activity" (NEDA) domains.
    Saied A; Elsaid N; Azab A
    Steroids; 2019 Sep; 149():108401. PubMed ID: 31100292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute relapses in multiple sclerosis.
    Berkovich R
    Neurotherapeutics; 2013 Jan; 10(1):97-105. PubMed ID: 23229226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronotherapy using corticosteroids for multiple sclerosis relapses.
    Glass-Marmor L; Paperna T; Ben-Yosef Y; Miller A
    J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):886-8. PubMed ID: 17056624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy and multiple sclerosis: a 2-year experience.
    Orvieto R; Achiron R; Rotstein Z; Noy S; Bar-Hava I; Achiron A
    Eur J Obstet Gynecol Reprod Biol; 1999 Feb; 82(2):191-4. PubMed ID: 10206414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of multiple sclerosis during pregnancy - safety considerations.
    Thöne J; Thiel S; Gold R; Hellwig K
    Expert Opin Drug Saf; 2017 May; 16(5):523-534. PubMed ID: 28333552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postpartum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
    Fragoso YD; Adoni T; Alves-Leon SV; Azambuja ND; Barreira AA; Brooks JB; Carneiro DS; Carvalho MJ; Claudino R; Comini-Frota ER; Domingues RB; Finkelsztejn A; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Grzesiuk AK; Kaimen-Maciel DR; Mendes MF; Morales NM; Morales RR; Muniz A; Papais-Alvarenga RM; Parolin MK; Ribeiro SB; Ruocco HH; Salgado PR; Siquineli F; Souza DB; Tosta ED; Vasconcelos CC; Almeida SM; Bernardes DF; Castro SN; Gama RA; Gomide FA; Finkelzstejn J; Lopes J; Lourenco FH; Lourenco GA; Oliveira CL; Oliveira FT; Oliveira LF; Patroclo CB; Pereira WL; Safanelli J; Sahdo AM; Saldanha PC; Shinzato YF; Souza JM; Zani DE
    Health Care Women Int; 2015; 36(10):1072-80. PubMed ID: 25187102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
    Köpke S; Kasper J; Mühlhauser I; Nübling M; Heesen C
    Mult Scler; 2009 Jan; 15(1):96-104. PubMed ID: 18845657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female gender and reproductive factors affecting risk, relapses and progression in multiple sclerosis.
    D'hooghe MB; D'Hooghe T; De Keyser J
    Gynecol Obstet Invest; 2013; 75(2):73-84. PubMed ID: 23343711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids in the treatment of multiple sclerosis.
    Myhr KM; Mellgren SI
    Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical management of multiple sclerosis: the treatment paradigm and issues of patient management.
    Stuart WH
    J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S19-25. PubMed ID: 15253686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.